Rare diseases
Investigational molecules
Locations
Back to Germany19 clinical trials in Falkensee, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
GermanyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GermanyStudy on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight
GermanyStudy on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes
GermanyStudy of AZD9550 and AZD6234 combination for weight loss in people with obesity or overweight with health complications
GermanyStudy on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes
GermanyStudy Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 2 Diabetes Mellitus management and glycemic control, evaluating new therapeutic approaches including novel compounds and established treatments.
Multiple trials are investigating both single and combination therapies for improving patient outcomes.
Comprehensive studies addressing atherosclerotic cardiovascular disease and cholesterol management, examining innovative treatments for reducing major adverse cardiovascular events.
Research focuses on comparing effectiveness of different therapeutic approaches for cholesterol control.
Groundbreaking research combining treatments for chronic kidney disease and metabolic conditions, including studies on weight management and obesity-related complications.
Trials evaluate combination therapies targeting multiple health conditions simultaneously.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
